Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Innovation relationships

Career planning is a necessary component of an overall approach to quality. Each employee should be viewed as having a career within the organization. People are more likely to take an innovative approach when they know that they have a long-term relationship with the organization. Confirm records and examine career plans. ... [Pg.196]

Constructing the model is an area where innovative effort is needed to maximize the validity of the model. The model will vary from industry to industry, but a simple one can start with a relationship between the number of employee hours and the output produced in each discrete activity area on the site, e.g. [Pg.72]

What should not be done, because it is so ineffective and which is still widely done because it is considered by administrators to be economically efficient , is to give teachers two or three half-day lectures on the innovation and then provide them with no on-site and sensitive, interactive, support to relate it to the particular circumstances in their own schools. Changing the curriculum, teaching, and learning, in respect of the triplet relationship requires the above guidelines to be clearly bom in mind if the formal and perceived curricula are to be mutually congment. [Pg.343]

All piroxicam batches were manufactured in compliance with Good Manufacturing Practices, and three formulations having fast, moderate, and slow dissolution were chosen for comparison to a lot of the innovator s product in a human bioavailability study [100]. The resulting pharmacokinetic data provided still another opportunity to examine the effects of formulation variables. To explore the relationship between the in vitro dissolution of piroxicam from these capsules and in vivo absorption, Polli [ 102] used the following previously described [145] deconvolution-based model ... [Pg.372]

FIGURE 6.1 Relationship between H2S03 and HS03 at various pH values. (Taken from Krofta, M. and Wang, L.K., Design of Innovative Flotation-Filtration Wastewater Treatment Systems for a Nickel-Chromium Plating Plant, U.S. Department of Commerce, National Technical Information Service, Springfield, VA, Technical Report PB-88-200522/AS, January 1984.)... [Pg.242]

This chapter offers an overview of the role played by technical information in the development of innovation and the necessary incentives for its creation, and at the same time the implications for the pharmaceutical sector. To this end, we present the basis and the significance of the patent system, we offer an analysis of the impact of this system, and lasdy we present a reflection on the future of the system and its relationship with the pharmaceutical industry. [Pg.22]

If we consider that at least development costs should be reimbursed, an efficient protection system will give rise to a set of broad values. Innovations with development costs x would result in compensation amounting to at least x. Once incurred, development costs are irrecoverable they are sunk costs. Any discontinuity in the relationship between development costs and their reimbursement would give rise to inefficiencies capital would be attracted to a greater or lesser extent towards certain innovative projects. [Pg.23]

The probability of expansion of a therapeutic innovation shows a positive relationship with the degree of innovation it incorporates, the age of the molecule, the size of the laboratory, the economic results obtained from the product and its previous authorization in the UK. [Pg.221]

In chapter 4 of his thesis, Borrell17 studies selective financing and price-cap regulation. The model he applies, Dixit and Stiglitz s monopolistic competition model, poses certain problems. The preference for variety and the fact that utility depends on the number of units consumed are not so clear as in other markets. The model does not take into account the complex relationship between doctor and patient. The fact that innovation only represents a fixed cost also raises doubts. [Pg.224]

Two basic procurement functions exist for resale or purchasing for consumption or conversion (Dobler et al. 1977, p. 4). Procurement is a core function of the business (Dobler et al. 1977, p. 5). Key objectives in procurement are to procure specified objects at a defined quality from suppliers, achieve cost savings and minimum prices for these objects and ensure continuous supply and foster joined innovations with suppliers based on contracts and a supplier relationship management. [Pg.44]

Skeggs innovative step, the introduction of air bubbles into the flowing stream, attempted to minimize the time taken for a steady-state condition to be reached in the detector. The definitive description of dispersion in segmented streams (Snyder [37]) showed a complex relationship between internal diameter, liquid flow rate, segmentation frequency, residence time in the flow system, viscosity of the hquid and surface tension. [Pg.54]

This book is an international collaborative effort, with authors from Canada, France, the Federal Republic of Germany, Great Britain, Italy, Japan, Sweden, Switzerland, and the United States. It is not possible to cover all aspects of this subject in a single volume, but the contributions here are broadly representative of innovative work in the field. The order of the chapters is developed from the relationship of the topics and is not necessarily related to the sequence of contributions at the two symposia from which much of the initial material was derived. [Pg.353]

The positive relationship between income of those affected by a disease and the amount of research undertaken into pharmaceuticals for that disease has been empirically conhrmed in a variety of studies, including Lanjouw and MacLeod (2005) and Lichtenberg (2005a). The prevalence of a disease in some developing countries has often been attributed to poor food, water, and sanitation or access to treatment and may not reflect an absence of useful pharmaceuticals. In such cases it may be factors other than pharmaceutical innovation that need to be addressed. However, even if other solutions are possible, there may also be situations in which a pharmaceutical solution would be the most cost effective, if it were available. For example, it may... [Pg.77]


See other pages where Innovation relationships is mentioned: [Pg.90]    [Pg.700]    [Pg.90]    [Pg.700]    [Pg.101]    [Pg.358]    [Pg.194]    [Pg.334]    [Pg.334]    [Pg.1]    [Pg.157]    [Pg.157]    [Pg.218]    [Pg.8]    [Pg.79]    [Pg.723]    [Pg.7]    [Pg.117]    [Pg.38]    [Pg.1]    [Pg.13]    [Pg.128]    [Pg.246]    [Pg.607]    [Pg.49]    [Pg.7]    [Pg.14]    [Pg.27]    [Pg.63]    [Pg.235]    [Pg.246]    [Pg.249]    [Pg.276]    [Pg.15]    [Pg.20]    [Pg.141]   
See also in sourсe #XX -- [ Pg.50 ]




SEARCH



Innovation relationship between open

© 2024 chempedia.info